Search

everythinglearnresearchcommunity

for

Search:↓

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Nilotinib can cause generalized keratosis pilaris.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Newly made nicotinamide compounds could potentially treat cancer.

Most patients experienced significant but reversible hair loss during treatment.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

The new platinum complexes effectively increased survival in rats with tumors, despite some reversible side effects.

Nilotinib can cause skin issues like red bumps and hair loss.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.